Cargando…
Brain metastases in Asian HER2-positive breast cancer patients: anti-HER2 treatments and their impact on survival
BACKGROUND: In Asia, large-scale studies on anti-HER2 treatment in HER2-positive breast cancer patients with brain metastases are limited. We studied the treatment patterns of these patients in Asia to evaluate the impact of anti-HER2 treatment on the time to occurrence of brain metastases (TTBM) an...
Autores principales: | Yap, Y S, Cornelio, G H, Devi, B C R, Khorprasert, C, Kim, S B, Kim, T Y, Lee, S C, Park, Y H, Sohn, J H, Sutandyo, N, Wong, D W Y, Kobayashi, M, Landis, S H, Yeoh, E M, Moon, H, Ro, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461152/ https://www.ncbi.nlm.nih.gov/pubmed/22918394 http://dx.doi.org/10.1038/bjc.2012.346 |
Ejemplares similares
-
Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients
por: Kim, S T, et al.
Publicado: (2018) -
BioPATH: A Biomarker Study in Asian Patients with HER2+ Advanced Breast Cancer Treated with Lapatinib and Other Anti-HER2 Therapy
por: Kim, Sung-Bae, et al.
Publicado: (2019) -
Gene therapy using plasmid DNA-encoded anti-HER2 antibody for cancers that overexpress HER2
por: Kim, H, et al.
Publicado: (2016) -
Safety and efficacy of HER2 blockade by trastuzumab-based chemotherapy-containing combination strategies in HER2+ gastroesophageal adenocarcinoma
por: Catenacci, D.V.T., et al.
Publicado: (2021) -
Real-world treatment in patients with HER2+ metastatic breast cancer: Treatment decisions in HER2+ mBC
por: Colomer, R., et al.
Publicado: (2017)